Seahorse XF96 Extracellular Flux Analyzer
Seahorse XF96 细胞外通量分析仪
基本信息
- 批准号:8447968
- 负责人:
- 金额:$ 17.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-27 至 2014-06-26
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAgingBioenergeticsBiological AssayCaloric RestrictionCardiac MyocytesCardiovascular DiseasesCell CountCell RespirationCellsCoupledDevelopmentDiseaseElementsEnvironmentEnzymesEvaluationFundingGenetic ModelsGenus HippocampusGlycolysisGrowthHealthHepatocyteHomeostasisHumanInjection of therapeutic agentInsulin ResistanceMalignant NeoplasmsMeasurementMeasuresMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMitochondriaModelingMonitorMusMuscle FibersMutationNeurodegenerative DisordersNeuronsNon-Insulin-Dependent Diabetes MellitusNutrientOrganismOxidative PhosphorylationOxygen ConsumptionPathogenesisPathologic ProcessesPhysical activityPhysiologicalPhysiological ProcessesPreclinical Drug EvaluationProtein-Folding DiseaseResearchResearch PersonnelResistance developmentRespirationSignal TransductionTechnologyTimecancer cellextracellularfatty acid oxidationinhibitor/antagonistinsightinstrumentmitochondrial dysfunctionrespiratoryresponse
项目摘要
DESCRIPTION: We are requesting funds to purchase a Seahorse XF96 Extracellular Flux Analyzer, an instrument that profiles the metabolic activity and bioenergetic state of cells non-invasively, in minutes, and in a medium/high- throughput manner. The Seahorse XF96 Extracellular Flux Analyzer uses a simple microplate format to simultaneously measure oxygen consumption (cellular respiration) and extracellular acidification rates, in real time. Combined with the use of different substrates for energy and various inhibitors of specific enzymes and metabolic pathways, which can be delivered automatically via four integrated injection ports, the Seahorse Extracellular Flux Analyzer provides an unprecedented, thorough and fast assessment of oxidative phosphorylation, glycolysis, nutrient utilization, fatty acid oxidation, coupled vs. uncoupled respiration, and spare respiratory capacity of cells. There is currently no other single instrument that can perform the same range of metabolic assays in a 96-well format. Mitochondria function and proper substrate utilization are central to most physiologic processes important for human health, including growth, energy homeostasis, capacity for physical activity, and aging. Mitochondrial dysfunction has been implicated in the initiation, development and/or pathogenesis of a wide variety of diseases, including metabolic diseases (e.g. insulin resistance and development of type 2 diabetes), cancer, neurodegenerative diseases, and cardiovascular disease. The requested Seahorse XF96 Extracellular Flux Analyzer will enable a minimum of 12 investigators, which currently have no access to a similar instrument or technology, to gain insights into the cellular metabolism of a wide range of cells and organisms used to model physiological and pathological processes (including primary hepatocytes, adipocytes, neurons, cardiomyocytes, cancer cells, myotubes, and worms). The key elements of the Seahorse XF96 Extracellular Flux Analyzer that make it ideally suited for the specific needs of the users are the ability of the instrument to: 1) monitor attached cells (a crucial consideration for neurons, adipocytes, hepatocytes, and myotubes, used by 7 of 12 investigators); 2) obtain reliable measurements from small numbers of cells (crucial for 6 users that derive primary cells from mouse genetic models; and, 3) offer a medium/high throughput format, thereby enabling drug screening (5 projects) and evaluation of responses to a wide range of physiologic signals, environmental insults, and genetic alterations (important for all projects). The Seahorse XF96 Extracellular Flux Analyzer is unsurpassed in the combination of features that make it ideally suited to the studies of the current users. The instrument will be placed in a multi-user appropriate environment, readily accessible to all users, and available to new users. In summary, by providing a comprehensive assessment of cellular metabolism and mitochondrial function, the Seahorse XF96 Extracellular Flux Analyzer will facilitate and enhance our research on metabolism and metabolic diseases, cancer, neurodegenerative diseases, aging, calorie restriction, and diseases of protein folding.
描述:我们正在申请资金购买 Seahorse XF96 细胞外通量分析仪,该仪器可在几分钟内以中/高通量方式非侵入性地分析细胞的代谢活动和生物能状态。 Seahorse XF96 细胞外通量分析仪使用简单的微孔板形式,实时同时测量耗氧量(细胞呼吸)和细胞外酸化率。结合使用不同的能量底物以及特定酶和代谢途径的各种抑制剂(可通过四个集成注射口自动输送),Seahorse 细胞外通量分析仪可对氧化磷酸化、糖酵解、营养利用、脂肪酸氧化、偶联与非偶联提供前所未有的、彻底和快速的评估 呼吸,以及细胞的备用呼吸能力。目前还没有其他单一仪器能够以 96 孔格式执行相同范围的代谢测定。线粒体功能和适当的底物利用对于对人类健康至关重要的大多数生理过程至关重要,包括生长、能量稳态、体力活动能力和衰老。线粒体功能障碍与多种疾病的发生、发展和/或发病机制有关,包括代谢疾病(例如胰岛素抵抗和2型糖尿病的发展)、癌症、神经退行性疾病和心血管疾病。所要求的 Seahorse XF96 细胞外通量分析仪将使至少 12 名目前无法使用类似仪器或技术的研究人员能够深入了解用于模拟生理和病理过程(包括原代肝细胞、脂肪细胞、神经元、心肌细胞、癌细胞、肌管和细胞)的各种细胞和生物体的细胞代谢。 蠕虫)。 Seahorse XF96 细胞外通量分析仪非常适合用户的特定需求,其关键要素是该仪器能够: 1) 监测附着细胞(神经元、脂肪细胞、肝细胞和肌管的一个重要考虑因素,12 名研究人员中有 7 名使用); 2) 从少量细胞中获得可靠的测量结果(对于从小鼠遗传模型中获得原代细胞的 6 个用户至关重要;3)提供中/高通量格式,从而实现药物筛选(5 个项目)和评估对各种生理信号、环境损害和遗传改变的反应(对所有项目都很重要)。 Seahorse XF96 细胞外通量分析仪在功能组合方面无与伦比,使其非常适合当前用户的研究。该仪器将放置在适合多用户的环境中,所有用户都可以轻松访问,并且新用户也可以使用。总之,通过对细胞代谢和线粒体功能进行全面评估,Seahorse XF96细胞外通量分析仪将促进和加强我们对代谢和代谢疾病、癌症、神经退行性疾病、衰老、热量限制和蛋白质折叠疾病的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Enrique Saez其他文献
Enrique Saez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Enrique Saez', 18)}}的其他基金
Impact of Heme Homeostasis on Adipocyte Function
血红素稳态对脂肪细胞功能的影响
- 批准号:
10398012 - 财政年份:2019
- 资助金额:
$ 17.5万 - 项目类别:
Impact of Heme Homeostasis on Adipocyte Function
血红素稳态对脂肪细胞功能的影响
- 批准号:
9975170 - 财政年份:2019
- 资助金额:
$ 17.5万 - 项目类别:
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia
靶向脂肪细胞脂肪酶治疗胰腺癌相关恶病质
- 批准号:
8571857 - 财政年份:2013
- 资助金额:
$ 17.5万 - 项目类别:
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia
靶向脂肪细胞脂肪酶治疗胰腺癌相关恶病质
- 批准号:
8708010 - 财政年份:2013
- 资助金额:
$ 17.5万 - 项目类别:
A Genome-wide RNAi Screening Platform for the Common Lab
通用实验室的全基因组 RNAi 筛选平台
- 批准号:
8310233 - 财政年份:2009
- 资助金额:
$ 17.5万 - 项目类别:
A Genome-wide RNAi Screening Platform for the Common Lab
通用实验室的全基因组 RNAi 筛选平台
- 批准号:
8111236 - 财政年份:2009
- 资助金额:
$ 17.5万 - 项目类别:
A Genome-wide RNAi Screening Platform for the Common Lab
通用实验室的全基因组 RNAi 筛选平台
- 批准号:
7900849 - 财政年份:2009
- 资助金额:
$ 17.5万 - 项目类别:
Nuclear Receptor Control of Glucose and Lipid Metabolism
葡萄糖和脂质代谢的核受体控制
- 批准号:
7582268 - 财政年份:2008
- 资助金额:
$ 17.5万 - 项目类别:
Nuclear Receptor Control of Glucose and Lipid Metabolism
葡萄糖和脂质代谢的核受体控制
- 批准号:
7781343 - 财政年份:2008
- 资助金额:
$ 17.5万 - 项目类别:
Nuclear Receptor Control of Glucose and Lipid Metabolism
葡萄糖和脂质代谢的核受体控制
- 批准号:
8055439 - 财政年份:2008
- 资助金额:
$ 17.5万 - 项目类别:
相似海外基金
The relationship between blood based bioenergetics and muscle function, mobility, and aging
基于血液的生物能学与肌肉功能、活动能力和衰老之间的关系
- 批准号:
10363365 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
The relationship between blood based bioenergetics and muscle function, mobility, and aging
基于血液的生物能学与肌肉功能、活动能力和衰老之间的关系
- 批准号:
10569677 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Coordinated mechanisms to rescue bioenergetics and sarcopenia in aging
拯救衰老过程中生物能学和肌肉减少症的协调机制
- 批准号:
10672292 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10426408 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10317378 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
- 批准号:
10634739 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10480897 - 财政年份:2020
- 资助金额:
$ 17.5万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10083227 - 财政年份:2020
- 资助金额:
$ 17.5万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10471062 - 财政年份:2020
- 资助金额:
$ 17.5万 - 项目类别: